PremiumThe FlyEledon Pharmaceuticals initiated with a Buy at Guggenheim Eledon Pharmaceuticals highlights recent business milestones, 2025 outlook Eledon Pharma Adjusts CEO Bonus Structure PremiumCompany AnnouncementsEledon Pharmaceuticals Announces $85 Million Stock Offering Eledon Pharmaceuticals Reports Promising Trial Results for Tegoprubart Eledon announces data for islet transplant recipients treated with tegoprubart PremiumThe FlyEledon enrolls 80th participant in ongoing Phase 2 BESTOW trial Eledon Pharmaceuticals Enacts Key Proposals and Board Changes Eledon gives data on tegoprubart for rejection prevention in kidney transplant 
